Sqz Biotechnologies Co (SQZB)

Sqz Biotechnologies Co is a clinical-stage biotechnology company listed on OTC Markets under the ticker SQZB. The company is focused on developing cell-based therapies for cancer, infectious diseases, and other serious illnesses. Its lead program, SQZ-PBMC-HPV, is being studied in Phase I as both a standalone treatment and in combination with immuno-oncology agents for HPV16-positive advanced or metastatic solid tumors, including cancers of the cervix, head and neck, anus, penis, vulva, and vagina. The pipeline also includes SQZ-AAC-HPV and SQZ-eAPC-HPV, the latter of which is also in Phase I testing for similar HPV16-positive tumor settings. In addition, the company is advancing its SQZ Activating Antigen Carriers and SQZ Tolerizing Antigen Carriers platforms. Sqz Biotechnologies was incorporated in 2013 and is based in Watertown, Massachusetts.

Jump directly to the stock analysis sections supported by the latest available data.